Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hallucinations in Parkinson's disease].

A Moser1, J Hagenah, D Kömpf

  • 1Klinik für Neurologie des Universitätsklinikums Schleswig-Holstein, Campus und Universität Lübeck, Lübeck. moser_a@neuro.mu-lubeck.de

Der Nervenarzt
|April 23, 2003
PubMed
Summary

Psychiatric symptoms like visual hallucinations are common in Parkinson's disease, often linked to L-dopa or dopamine agonist treatments. Managing medication and neurotransmitter systems is key to treating these hallucinations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical aspects of umbilical cord cannulation during transfer from the uterus to a liquid-based perinatal life support system for extremely premature infants a qualitative generic study.

PloS one·2023
Same author

Circadian regulation of hedonic appetite in mice by clocks in dopaminergic neurons of the VTA.

Nature communications·2020
Same author

Effects of Health Risk Assessment and Counselling on Fruit and Vegetable Intake in Older People: A Pragmatic Randomised Controlled Trial.

The journal of nutrition, health & aging·2020
Same author

The stabilization effect of the conjoint tendon in reverse total shoulder arthroplasty.

Clinical biomechanics (Bristol, Avon)·2019
Same author

Improving End-of-Life Care and Advance Care Planning for Frail Older Adults in Canad.

The Journal of frailty & aging·2018
Same author

Switching "on" and "off" the adhesion in stimuli-responsive elastomers.

Soft matter·2018

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Context:

  • Parkinson's disease (PD) frequently presents with psychiatric symptoms during its course and treatment.
  • Therapies involving Levodopa (L-dopa) or dopamine agonists can increase dream activity, potentially signaling paranoid hallucinatory psychosis.
  • Isolated visual hallucinations in PD patients are often medication-induced, affecting up to 30% and involving complex imagery.

Purpose:

  • To highlight the connection between Parkinson's disease treatments and psychiatric symptoms, particularly visual hallucinations.
  • To identify visual hallucinations as potential early indicators of psychosis in Parkinson's patients.
  • To outline current therapeutic strategies for managing medication-induced visual hallucinations in Parkinson's disease.

Summary:

Related Experiment Videos

  • Psychiatric symptoms, including increased dream activity and visual hallucinations, are prevalent in Parkinson's disease (PD) patients undergoing treatment.
  • Levodopa (L-dopa) and dopamine agonists commonly trigger these symptoms, which can precede or indicate paranoid hallucinatory psychosis.
  • Visual hallucinations in PD are likely due to the combined impact on central nervous system dopaminergic and serotonergic pathways.

Impact:

  • Understanding the link between PD medications and psychiatric symptoms can lead to earlier detection and intervention.
  • This knowledge aids clinicians in adjusting anti-Parkinsonian drug dosages and types to mitigate adverse effects.
  • The study emphasizes the importance of managing fluid/electrolyte balance and considering specific medications like serotonin antagonists for hallucination control.